Minghe Lv

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Epithelial Mesenchymal Transition

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Radiation Therapy

Top Venues

Journal of lipids

Current pharmaceutical design

The breast journal

Immunity, inflammation and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Minghe Lv, Shali Shao, Yajing Du, Xibing Zhuang, Xiangdong Wang, Tiankui Qiao
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients. Journal of lipids 2024 (2024)
Minghe Lv, Rong Ding, Peizhen Ma, Yue Feng, Su Zeng, Yang Zhang, Wenhao Shen, Wenhui Guan, E Xiangyu, Hongwei Zeng, Jingping Yu
Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis. Current pharmaceutical design (2024)
Minghe Lv, Rong Ding, Peizhen Ma, Yue Feng, Su Zeng, Yang Zhang, Wenhao Shen, Wenhui Guan, E Xiangyu, Hongwei Zeng, Jingping Yu
Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis. Current pharmaceutical design 30 (9) (2024)
Minghe Lv, Shali Shao, Yajing Du, Xibing Zhuang, Xiangdong Wang, Tiankui Qiao
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients. Journal of lipids 2024 (2024)
Minghe Lv, Kun Wang, Zhiyuan Zhang, Zhen Zhang, Juefeng Wan
The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection. Cancer medicine (2023)
Minghe Lv
MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. The breast journal 2023 (2023)
Minghe Lv
MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. The breast journal 2023 (2023)
Minghe Lv, Xibing Zhuang, Shali Shao, Xuan Li, Yunfeng Cheng, Duojiao Wu, Xiangdong Wang, Tiankui Qiao
Myeloid-Derived Suppressor Cells and CD68 + CD163 + M2-Like Macrophages as Therapeutic Response Biomarkers Are Associated with Plasma Inflammatory Cytokines: A Preliminary Study for Non-Small Cell Lung Cancer Patients in Radiotherapy. Journal of immunology research 2022 (2022)
Minghe Lv
WD repeat domain 6 as a novelty prognostic biomarker correlates with immune infiltration in lung cancer: A preliminary study. Immunity, inflammation and disease 10 (9) (2022)
Minghe Lv, Lumeng Luo, Xue Chen
The landscape of prognostic and immunological role of myosin light chain 9 (MYL9) in human tumors. Immunity, inflammation and disease (2021)